Astria Therapeutics (ATXS)
(Delayed Data from NSDQ)
$11.87 USD
+0.56 (4.95%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $11.85 -0.02 (-0.17%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Astria Therapeutics, Inc. (ATXS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$25.14 | $35.00 | $16.00 | 122.28% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Astria Therapeutics, Inc. comes to $25.14. The forecasts range from a low of $16.00 to a high of $35.00. The average price target represents an increase of 122.28% from the last closing price of $11.31.
Analyst Price Targets (7 )
Broker Rating
Astria Therapeutics, Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, seven are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 7 | 6 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/14/2024 | Evercore Partners | Liisa A Bayko | Not Available | Strong Buy |
8/13/2024 | Wedbush Securities | Laura Chico | Strong Buy | Strong Buy |
8/13/2024 | H.C. Wainwright & Co. | Joseph Pantginis | Strong Buy | Strong Buy |
8/12/2024 | LifeSci Capital | Sam Slutsky | Strong Buy | Strong Buy |
7/29/2024 | Cowen & Co. | Stacy Ku | Not Available | Strong Buy |
6/17/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
3/25/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 7 |
Average Target Price | $25.14 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 83 of 252 |
Current Quarter EPS Est: | -0.43 |
ATXS FAQs
Astria Therapeutics, Inc. (ATXS) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 7 brokerage firms.
The average price target for Astria Therapeutics, Inc. (ATXS) is $25.14. The current on short-term price targets is based on 6 reports.
The forecasts for Astria Therapeutics, Inc. (ATXS) range from a low of $16 to a high of $35. The average price target represents a increase of $111.79 from the last closing price of $11.87.
The current UPSIDE for Astria Therapeutics, Inc. (ATXS) is 111.79%
Based on short-term price targets offered by seven analysts, the average price target for Astria Therapeutics, Inc. comes to $25.14. The forecasts range from a low of $16.00 to a high of $35.00. The average price target represents an increase of 122.28% from the last closing price of $11.31.